A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Progressive Pulmonary Fibrosis (TETON-PPF)

Investigator: Sandeep Sahay, MD

Study Coordinator: Rosa Barrosa da Costa

Status: Open Not Enrolling

ClinicalTrials.gov Number: NCT05943535

Phone: 713.441.5660

Protocol Number: PRO00038122

Description

Study RIN-PF-305 is designed to evaluate the safety and efficacy of inhaled treprostinil in subjects with progressive pulmonary fibrosis (PPF) over a 52-week period.
More to Explore